STEVENS PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
STEVENS PHARMA
Largest movements
- Cash -€37,170
down €37,170 (-24.7%), from €150,467 to €113,297
mainly Trade debts (-€49,305) and Other debts (-€43,810)
- Intangible fixed assets -€9,000
down €9,000 (-20.9%), from €43,067 to €34,067
- Trade debts -€49,305
down €49,305 (-67.7%), from €72,863 to €23,557
- Other debts -€43,810
down €43,810 (-54.4%), from €80,488 to €36,678
- Reserves +€39,269
up €39,269 (+17.6%), from €223,417 to €262,686
of which Distributable reserves: +€39,269
- Tax, wage and social debts +€9,783
up €9,783 (+82.7%), from €11,826 to €21,608
of which Taxes: +€9,547
- Gross operating margin +€31,791
up €31,791 (+23.9%), from €133,277 to €165,069
- Depreciation +€7,841
up €7,841 (+80.5%), from €9,735 to €17,576
- Taxes +€5,634
up €5,634 (+52.5%), from €10,727 to €16,361
- Staff costs +€2,180
up €2,180 (+2.4%), from €89,447 to €91,627
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €450,567 | €406,503 | -€44,064 | -9.8% |
| Fixed assets | 21/28 | €85,285 | €74,013 | -€11,272 | -13.2% |
| Intangible fixed assets | 21 | €43,067 | €34,067 | -€9,000 | -20.9% |
| Tangible fixed assets | 22/27 | €42,218 | €39,946 | -€2,272 | -5.4% |
| Plant, machinery and equipment | 23 | €23,674 | €20,923 | -€2,751 | -11.6% |
| Furniture and vehicles | 24 | €3,975 | €2,831 | -€1,145 | -28.8% |
| Other tangible fixed assets | 26 | €14,568 | €16,192 | +€1,624 | +11.1% |
| Current assets | 29/58 | €365,282 | €332,490 | -€32,792 | -9.0% |
| Stocks and contracts in progress | 3 | €160,142 | €164,337 | +€4,195 | +2.6% |
| Stocks | 30/36 | €160,142 | €164,337 | +€4,195 | +2.6% |
| Amounts receivable within one year | 40/41 | €44,529 | €44,683 | +€154 | +0.3% |
| Trade receivables | 40 | €44,466 | €44,683 | +€217 | +0.5% |
| Other amounts receivable | 41 | €63 | €0 | -€63 | -100.0% |
| Cash at bank and in hand | 54/58 | €150,467 | €113,297 | -€37,170 | -24.7% |
| Deferred charges and accrued income | 490/1 | €10,144 | €10,173 | +€29 | +0.3% |
| Total equity and liabilities | 10/49 | €450,567 | €406,503 | -€44,064 | -9.8% |
| Equity | 10/15 | €285,391 | €324,659 | +€39,269 | +13.8% |
| Contributions | 10/11 | €61,973 | €61,973 | = | 0.0% |
| Capital | 10 | €61,973 | €61,973 | = | 0.0% |
| Issued capital | 100 | €61,973 | €61,973 | = | 0.0% |
| Reserves | 13 | €223,417 | €262,686 | +€39,269 | +17.6% |
| Non-distributable reserves | 130/1 | €6,197 | €6,197 | = | 0.0% |
| Legal reserve | 130 | €6,197 | €6,197 | = | 0.0% |
| Distributable reserves | 133 | €217,220 | €256,489 | +€39,269 | +18.1% |
| Amounts payable | 17/49 | €165,176 | €81,843 | -€83,333 | -50.5% |
| Amounts payable within one year | 42/48 | €165,176 | €81,843 | -€83,333 | -50.5% |
| Trade debts | 44 | €72,863 | €23,557 | -€49,305 | -67.7% |
| Suppliers | 440/4 | €72,863 | €23,557 | -€49,305 | -67.7% |
| Taxes, remuneration and social security | 45 | €11,826 | €21,608 | +€9,783 | +82.7% |
| Taxes | 450/3 | €727 | €10,275 | +€9,547 | +1312.8% |
| Remuneration and social security | 454/9 | €11,098 | €11,334 | +€235 | +2.1% |
| Other amounts payable | 47/48 | €80,488 | €36,678 | -€43,810 | -54.4% |
| Remuneration, social security and pensions | 62 | €89,447 | €91,627 | +€2,180 | +2.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €9,735 | €17,576 | +€7,841 | +80.5% |
| Other operating charges | 640/8 | €561 | €579 | +€18 | +3.2% |
| Gross operating margin | 9900 | €133,277 | €165,069 | +€31,791 | +23.9% |
| Operating profit (loss) | 9901 | €33,535 | €55,287 | +€21,752 | +64.9% |
| Financial income | 75/76B | €982 | €577 | -€404 | -41.2% |
| Recurring financial income | 75 | €982 | €577 | -€404 | -41.2% |
| Financial charges | 65/66B | €62 | €234 | +€172 | +275.4% |
| Recurring financial charges | 65 | €62 | €234 | +€172 | +275.4% |
| Profit (loss) for the period before taxes | 9903 | €34,454 | €55,630 | +€21,176 | +61.5% |
| Income taxes | 67/77 | €10,727 | €16,361 | +€5,634 | +52.5% |
| Profit (loss) for the period | 9904 | €23,727 | €39,269 | +€15,542 | +65.5% |
| Profit (loss) for the period to be appropriated | 9905 | €23,727 | €39,269 | +€15,542 | +65.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.